TIBOLLA, GIANPAOLO
TIBOLLA, GIANPAOLO
Dipartimento di Scienze Farmacologiche e Biomolecolari
IDOL N342S variant, atherosclerosis progression and cardiovascular disorders in the Italian general population
2015 A. Dhyani, G. Tibolla, A. Baragetti, K. Garlaschelli, F. Pellegatta, L. Grigore, G.D. Norata, A.L. Catapano
PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling
2015 L. Braccini, E. Ciraolo, C.C. Campa, A. Perino, D.L. Longo, G. Tibolla, M. Pregnolato, Y. Cao, B. Tassone, F. Damilano, M. Laffargue, E. Calautti, M. Falasca, G.D. Norata, J.M. Backer, E. Hirsch
Targeting PCSK9 for Hypercholesterolemia
2014 G.D. Norata, G. Tibolla, A.L. Catapano
Statins and skeletal muscles toxicity: from clinical trials to everyday practice
2014 G.D. Norata, G. Tibolla, A.L. Catapano
HDL: To Treat or Not To Treat?
2014 A. Pirillo, G. Tibolla, G.D. Norata, A.L. Catapano
PCSK9 inhibition for the treatment of hypercholesterolemia:pPromises and emerging challenges
2014 G.D. Norata, G. Tibolla, A.L. Catapano
PCSK9 deficient mice are protected from neointima formation in carotid artery injury model
2013 N. Ferri, G. Tibolla, R. Baetta, P. Costet, A. Corsini, A.L. Catapano
Effect of proprotein convertase subtilisin kexin type 9 (PCSK9) on smooth muscle cell proliferation and migration
2013 N. Ferri, G. Tibolla, F. Maglione, P. Costet, A. Corsini, A.L. Catapano
Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis
2013 G. Tibolla, R. Piñeiro, D. Chiozzotto, I. Mavrommati, A.P. Wheeler, G.D. Norata, A.L. Catapano, T. Maffucci, M. Falasca
Gene silencing approaches for the management of dyslipidaemia
2013 G.D. Norata, G. Tibolla, A.L. Catapano
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels
2012 N. Ferri, G. Tibolla, A. Pirillo, F. Cipollone, A. Mezzetti, S. Pacia, A. Corsini, A.L. Catapano
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels
2012 N. Ferri, G. Tibolla, A. Pirillo, F. Cipollone, A. Mezzetti, S. Pacia, A. Corsini, A.L. Catapano
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels
2011 N. Ferri, G. Tibolla, A. Pirillo, F. Cipollone, A. Mezzetti, S. Pacia, A. Corsini, A.L. Catapano
Proprotein convertase subtilisin kexin type 9 (PCSK9)secreted by cultured smooth muscle cells reduces macrophages LDLR levels
2011 N. Ferri, G. Tibolla, A. Pirillo, F. Cipollone, A. Mezzetti, S. Pacia, A. Corsini, A.L. Catapano
PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 SECRETED BY CULTURED SMOOTH MUSCLE CELLS REDUCES MACROPHAGES LOW DENSITY LIPOPROTEIN RECEPTOR LEVELS AND FACILITATES SMOOTH MUSCLE CELL MIGRATION
2011 N. Ferri, G. Tibolla, A. Pirillo, F. Cipollone, A. Mezzetti, S. Pacia, A. Corsini, A.L. Catapano
Expression and secretion of PCSK9 from cultured smooth muscle cells: evidence for a direct role in atherogenesis
2011 N. Ferri, G. Tibolla, A. Pirillo, F. Cipollone, A. Mezzetti, S. Pacia, A. Corsini, A.L. Catapano
Proprotein convertase subtilisin/kexin type 9 (PCSK9): from structure-function relation to therapeutic inhibition
2011 G. Tibolla, G.D. Norata, R. Artali, F. Meneghetti, A.L. Catapano
Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency
2010 G. Tibolla, G.D. Norata, C. Meda, L. Arnaboldi, P. Uboldi, F. Piazza, C. Ferrarese, A. Corsini, A. Maggi, E. Vegeto, A.L. Catapano
Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population
2009 G.D. Norata, K. Garlaschelli, L. Grigore, G. Tibolla, S. Raselli, L. Redaelli, G. Buccianti, A.L. Catapano
Dihydrotestosterone decreases tumor necrosis factor-(alpha) and lipopolysaccharide-induced inflammatory response in human endothelial cells
2006 G.D. Norata, G. Tibolla, P.M. Seccomandi, A. Poletti, A.L. Catapano